NFL Week 10 preview: It’s make-or-break for teams in playoff contention
The 2020 NFL season has reached Week 10 and things aren’t getting any easier in terms of handling the coronavirus. — FOX News
The 2020 NFL season has reached Week 10 and things aren’t getting any easier in terms of handling the coronavirus. — FOX News
The school system, the nation’s largest, has had strikingly few virus cases. Even so, the mayor may end in-person classes because the city’s overall rate is surging. — New York Times: Top Stories
A man who claimed he was headed to Missouri to kill former U.S. Sen. Claire McCaskill was arrested Wednesday in Utah after troopers caught him driving up to 130 mph, according to court documents. — FOX News
• Metagenomi is a genomic medicines company pioneering precision gene editing systems to advance curative therapies for oncology and genetic diseases • Proprietary and wholly owned gene editing platform offers the potential to expand the range of treatable diseases and to improve patient
President Trump on Wednesday ripped a pre-election poll in the key battleground state of Wisconsin, which showed him trailing Joe Biden by a whopping 17 points, slamming it as “illegal suppression.” — FOX News
A manhunt continued Wednesday for the second suspect who remained at large just two days after Houston Police Sgt. Sean Rios was fatally gunned down after entering a hotel parking lot on his way to work, leaving behind four children. — FOX
Four pro-democracy figures were ousted from the legislature, prompting 15 others to vow to resign in solidarity, as Beijing cracks down on one of the city’s few remaining venues for political opposition. — NYT: Top Stories
Staten Island has bristled at coronavirus restrictions, but now has the highest positive test rate in the New York City. — NYT: Top Stories
Results for our CD19-targeted CAR T cell therapy lisocabtagene maraleucel (liso-cel) in patients with heavily pretreated mantle cell lymphoma and relapsed/refractory chronic lymphocytic leukemia Data showcasing BCMA-targeted CAR T cell therapy idecabtagene vicleucel (ide-cel), including updated results from the Phase 1 CRB-401